Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.3245 USD -0.01 ( 3.99%)
Last update at 2026-11-20T20:59:00Z
VOLUME
133920
Market Cap
107.09M

Momentum Score

…

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tablets, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Royale, High Wired, Effin', Miss Grass, Lowell Smokes, Flower by Edie Parker, 1906, AiroPro, and Miss Grass brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores, and third-party licensed retail cannabis stores. The company was formerly known as Ascend Wellness Holdings, LLC and changed its name to Ascend Wellness Holdings, Inc. in April 2021. Ascend Wellness Holdings, Inc. was incorporated in 2018 and is headquartered in Rochelle Park, New Jersey.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.32
Low
0.34
High
52 Week Price Range
0.34
Low
1.20
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Ascend Wellness Holdings Inc is a U.S. multi-state cannabis operator that cultivates, processes and sells medical and adult-use cannabis through owned cultivation and retail assets. Long-term growth drivers include expansion of retail footprint, rising consumer adoption as more states legalize, and scale benefits from vertical integration. Its diversified state presence and integrated operations may support revenue growth and market share gains.
Key investment risks include federal illegality affecting banking and taxation, state-level regulatory or licensing changes, intense competition among multi-state operators, and capital-intensive operations that could strain margins or financing.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.34
Dividend Yield
-
Revenue TTM
488.33M
Revenue Per Share
2.41
Gross Profit TTM
179.10M
Debt / Equity
-
ROE
-938.64%
Net Debt
218.72M
ROCE
-0.09%
Diluted EPS TTM
-0.55

Insight Announcement

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -66.81M -39.82M -14.76M -39.21M -80.94M
Minority interest - - - 0.00M 0.00M
Net income -118.19M -84.99M -48.21M -80.90M -122.66M
Selling general administrative 129.39M 144.48M 129.43M 137.09M 116.67M
Gross profit 169.68M 184.21M 155.12M 134.56M 135.97M
Reconciled depreciation 75.59M 68.12M 60.04M 38.24M 23.58M
Ebit - - - -6.77M -16.95M
Ebitda - - - 29.29M 6.63M
Non operating income net other - - - 0.76M 0.26M
Operating income -0.76M 4.75M -3.85M -7.53M -17.20M
Interest expense 51.17M 39.79M 36.98M 32.44M 63.99M
Tax provision 51.38M 45.17M 33.45M 41.69M 41.72M
Net interest income -51.17M -39.79M -36.98M -30.26M -63.99M
Non recurring - - - 5.00M 36.51M
Income tax expense - - - 41.69M 41.72M
Total revenue 500.58M 561.60M 518.59M 405.93M 332.38M
Total operating expenses 501.34M 556.85M 522.43M 142.09M 153.18M
Cost of revenue 330.90M 377.39M 363.47M 271.36M 196.41M
Total other income expense net -14.89M -4.78M 26.07M -6.77M -36.86M
Net income from continuing ops -118.19M -84.99M -48.21M -80.90M -122.66M
Net income applicable to common shares - - - -80.90M -122.66M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 907.93M 900.43M 919.55M 872.16M 723.44M
Intangible assets 196.07M 205.50M 221.45M 221.09M 59.27M
Other current assets 2.34M 0.35M 2.50M 162.72M 171.76M
Total liab 954.55M 828.63M 776.68M 708.75M 546.96M
Total stockholder equity -46.62M 71.80M 142.87M 163.41M 176.48M
Deferred long term liab - - - 33.61M 1.42M
Other current liab 7.07M 5.06M 6.77M 8.35M 7.82M
Common stock - - - 0.19M 0.17M
Capital stock 0.20M 0.20M 0.21M 0.19M 0.17M
Retained earnings -518.55M -400.36M -315.36M -267.15M -186.25M
Other liab - - - 48.68M 1.42M
Good will 58.45M 49.60M 47.54M 44.37M 42.97M
Other assets - - - 19.28M 19.57M
Cash 85.68M 88.25M 72.51M 74.15M 155.48M
Total current liabilities 109.01M 144.54M 92.69M 110.95M 117.39M
Net debt 218.72M 220.17M 236.21M 256.48M 103.31M
Short term debt - - - 11.33M 27.94M
Short long term debt 13.29M 73.88M 11.15M 11.33M 27.94M
Property plant equipment - - - 388.67M 239.66M
Total current assets 208.95M 229.38M 228.86M 198.74M 258.01M
Net tangible assets - - - -57.68M 117.21M
Net receivables 27.02M 36.54M 28.30M 36.81M 31.68M
Long term debt 291.10M 234.54M 297.56M 319.30M 230.85M
Inventory 84.71M 89.55M 95.29M 97.53M 65.59M
Accounts payable 20.91M 26.41M 34.69M 91.27M 81.64M
Common stock total equity - - - 0.19M 0.17M
Retained earnings total equity - - - -267.15M -186.25M
Non currrent assets other 14.99M 16.43M 23.06M 279.86M 19.57M
Non current assets total 698.98M 671.05M 690.69M 500.95M 298.93M
Capital lease obligations 325.23M 272.69M 264.75M 232.45M 199.96M
Long term debt total - - - 319.30M 230.85M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -37.20M -59.89M -2.44M -2.65M
Change to liabilities - - - 11.80M 25.41M
Total cashflows from investing activities - - - -114.25M -113.23M
Net borrowings 8.58M 0.73M -23.56M 76.22M 171.46M
Total cash from financing activities 5.11M -20.35M -17.08M 71.28M 252.35M
Change to operating activities - - - 7.92M -19.64M
Net income -118.19M -84.99M -48.21M -80.90M -122.66M
Change in cash -2.58M 15.75M -1.64M -81.33M 97.38M
Begin period cash flow 88.25M 72.51M 74.15M 155.48M 58.10M
End period cash flow 85.68M 88.25M 72.51M 74.15M 155.48M
Total cash from operating activities 38.05M 73.29M 75.33M -38.36M -41.74M
Issuance of capital stock 0.00M 0.00M 7.00M 0.00M 86.06M
Depreciation 75.59M 68.12M 60.04M 37.11M 22.22M
Other cashflows from investing activities - - - -30.17M -22.16M
Change to inventory -10.71M 1.81M -14.88M -43.81M -36.50M
Change to account receivables 7.92M -8.24M -14.20M -6.48M -1.34M
Sale purchase of stock -2.31M -2.75M 0.00M - 81.91M
Other cashflows from financing activities - - - -4.95M -1.01M
Change to netincome - - - 35.44M 62.75M
Capital expenditures 37.96M 35.23M 40.19M 81.64M 88.43M
Change receivables - - - -6.48M -1.34M
Cash flows other operating - - - 8.49M 8.38M
Cash and cash equivalents changes - - - -81.33M 97.38M
Change in working capital 64.08M 63.32M 26.18M -31.14M -32.84M
Stock based compensation 2.45M 18.61M 19.78M 18.98M 23.09M
Other non cash items 22.06M 20.52M 30.04M 21.87M 70.12M
Free cash flow 0.09M 38.06M 35.14M -164.25M -130.17M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AAWH
Ascend Wellness Holdings Inc
-0.01
3.99%
0.32 - 10.88 0.22 5.95 1.43 10.11
MKKGY
Merck KGaA ADR
-0.68
2.09%
31.83 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
163.45 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
0.38
1.77%
21.79 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
43.05 - 10.66 0.01 1.16 2.94 23.11

Profile*

Ascend Wellness Holdings Inc

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tablets, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Royale, High Wired, Effin', Miss Grass, Lowell Smokes, Flower by Edie Parker, 1906, AiroPro, and Miss Grass brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores, and third-party licensed retail cannabis stores. The company was formerly known as Ascend Wellness Holdings, LLC and changed its name to Ascend Wellness Holdings, Inc. in April 2021. Ascend Wellness Holdings, Inc. was incorporated in 2018 and is headquartered in Rochelle Park, New Jersey.

174 NJ-17, Rochelle Park, NJ, United States, 07662

646 661 7600

2200

Name Title Year Born
Mr. Abner B. Kurtin Founder & Exec. Chairman of The Board 1967
Mr. Francis Perullo Co-Founder, Interim Co-CEO, Pres, Chief Strategy Officer, Sec. & Director 1977
Mr. Daniel Neville Interim Co-CEO, CFO, Treasurer & Director 1986
Mr. David Gacom Chief Operating Officer NA
Mr. Roman Nemchenko Sr. VP & Chief Accounting Officer NA
Ms. Rebecca Conti Koar B.Sc. Sr. VP of Investor Relations NA
Ms. Robin Debiase Chief People Officer 1971
Mr. Christopher Melillo Chief Revenue Officer 1974
Jason Liotta Sr. VP of Fin. NA
Mr. Brian Miesieski Chief Brand Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…